Literature DB >> 27103395

Interleukin-12 (-1188) A/C and interferon-γ (+874) A/T gene polymorphisms in subacute sclerosing panencephalitis patients.

Nihal Olgac Dundar1, Pinar Gencpinar2, Nilgun Sallakci3, Ozgur Duman4, Senay Haspolat4, Banu Anlar5, Olcay Yegin6.   

Abstract

The two polymorphisms [IL-12 (-1188) A/C and the IFN-γ (+874) A/T)] are known to have functional consequences and henceforth were analyzed in subacute sclerosing panencephalitis (SSPE) patients to reveal a possible relation with these polymorphisms and this debilitating disease. For the IL-12 (-1188) A/C polymorphism, 78 patients and 90 healthy individuals were analyzed. An increase in the AA genotype was determined (p = 0.02, OR = 2.06). There was also a statistically significant difference between the control group and the patients with respect to the allele frequencies (p = 0.04, OR = 1.65). For the IFN-γ (+874) A/T polymorphism, 69 SSPE patients and 115 controls were studied and there was not a significant difference between the two groups. Our findings suggested that not the IFN-γ (+874) A/T but the IL-12 (-1188) A/C polymorphism is correlated with SSPE and having an AA genotype or A allele decreases the risk of developing SSPE by 2.06- and 1.65-fold, respectively.

Entities:  

Keywords:  Gene polymorphism; IFN-γ; IL-12; SSPE; Subacute sclerosing panencephalitis

Mesh:

Substances:

Year:  2016        PMID: 27103395     DOI: 10.1007/s13365-016-0442-7

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  26 in total

1.  Apoptosis in brain biopsies of subacute sclerosing panencephalitis patients.

Authors:  B Anlar; F Söylemezoğlu; B Elibol; T Dalkara; S Aysun; G Köse; D Belen; K Yalaz
Journal:  Neuropediatrics       Date:  1999-10       Impact factor: 1.947

2.  Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis.

Authors:  T Hara; S Yamashita; H Aiba; K Nihei; N Koide; R A Good; K Takeshita
Journal:  J Neurovirol       Date:  2000-04       Impact factor: 2.643

3.  Subacute sclerosing panencephalitis in Turkey: epidemiological features.

Authors:  K Yalaz; B Anlar; Y Renda; S Aysun; M Topcu; E Ozdirim
Journal:  J Trop Pediatr       Date:  1988-12       Impact factor: 1.165

4.  Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production.

Authors:  D Naniche; A Yeh; D Eto; M Manchester; R M Friedman; M B Oldstone
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 5.  Neuroprogressive disease of post-infectious origin: a review of a resurging subacute sclerosing panencephalitis (SSPE).

Authors:  P R Dyken
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2001

6.  Subacute sclerosing panencephalitis.

Authors:  M C Graves
Journal:  Neurol Clin       Date:  1984-05       Impact factor: 3.806

7.  Interferon production by cells infected with subacute sclerosing panencephalitis (SSPE) virus or measles virus.

Authors:  Shunji Hasegawa; Natsumi Mori; Mika Satomi; Da-Peng Jiang; Hak Hotta; Takeshi Matsushige; Takashi Ichiyama
Journal:  Cytokine       Date:  2011-10-02       Impact factor: 3.861

8.  Natural measles causes prolonged suppression of interleukin-12 production.

Authors:  S F Atabani; A A Byrnes; A Jaye; I M Kidd; A F Magnusen; H Whittle; C L Karp
Journal:  J Infect Dis       Date:  2001-05-30       Impact factor: 5.226

Review 9.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

10.  Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity.

Authors:  P Ling; M K Gately; U Gubler; A S Stern; P Lin; K Hollfelder; C Su; Y C Pan; J Hakimi
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

View more
  1 in total

Review 1.  Alcohol and multiple sclerosis: an immune system-based review.

Authors:  Maryam Fahim; Aryan Rafiee Zadeh; Pouria Shoureshi; Keyvan Ghadimi; Masoumeh Cheshmavar; Neda Sheikhinia; Mahdieh Afzali
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.